These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 18545985

  • 1. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG.
    Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
    [Abstract] [Full Text] [Related]

  • 2. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 4. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A, Giuffrida A.
    Neuropharmacology; 2018 Mar 01; 130():1-9. PubMed ID: 29169961
    [Abstract] [Full Text] [Related]

  • 5. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
    Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG.
    Neurosci Lett; 2006 Apr 24; 397(3):180-4. PubMed ID: 16378681
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE, Miller F, Palchik G, Deadwyler SA.
    Neuropharmacology; 2011 May 24; 60(6):944-52. PubMed ID: 21288475
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May 24; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 8. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 24; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 9. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec 24; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 10. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB.
    J Psychopharmacol; 2019 May 24; 33(5):606-614. PubMed ID: 30789299
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 24; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 12. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 24; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 13. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 24; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 14. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
    Roohbakhsh A, Keshavarz S, Hasanein P, Rezvani ME, Moghaddam AH.
    Basic Clin Pharmacol Toxicol; 2009 Nov 24; 105(5):333-8. PubMed ID: 19614892
    [Abstract] [Full Text] [Related]

  • 15. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.
    Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ.
    Neuropharmacology; 2017 Oct 24; 125():220-230. PubMed ID: 28754373
    [Abstract] [Full Text] [Related]

  • 16. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 24; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 17. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Vimalanathan A, Gidyk DC, Diwan M, Gouveia FV, Lipsman N, Giacobbe P, Nobrega JN, Hamani C.
    Neuropharmacology; 2020 Apr 24; 166():107965. PubMed ID: 31962287
    [Abstract] [Full Text] [Related]

  • 18. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul 24; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 19. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
    Seillier A, Martinez AA, Giuffrida A.
    Neuropsychopharmacology; 2013 Aug 24; 38(9):1816-24. PubMed ID: 23563893
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C, Markert A, Zimmer A.
    Eur Neuropsychopharmacol; 2015 Aug 24; 25(8):1388-96. PubMed ID: 25910421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.